A prospective randomized controlled clinical trial of Pingmu Decoction combined with acupuncture in the treatment of non-active thyroid-related ophthalmopathy
Not Applicable
Recruiting
- Conditions
- Thyroid associated ophthalmopathy
- Registration Number
- ITMCTR2100004405
- Lead Sponsor
- onghua Hospital, Shanghai University of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
1. Patients who meet the diagnostic criteria of TCM and Western medicine;
2. Patients aged 19-70 years;
3. Patients who refused surgery;
4. Patients with go history and normal serum thyroid hormone levels (FT3, FT4) for at least two months;
5. Those patients with informed consent, who have good compliance and are willing to accept treatment.
Exclusion Criteria
1. Other causes of exophthalmos: myopic exophthalmos, primary orbital tumor, orbital inflammatory pseudotumor, eye metastases and other diseases;
2. Mental patients;
3. Patients with severe primary and secondary cardiovascular and cerebrovascular diseases, liver and kidney diseases, hematopoietic system diseases, and hyperthyroid crisis tendency;
4. Pregnant or lactating women.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method TCM syndrome integral;Degree of exophthalmia;
- Secondary Outcome Measures
Name Time Method